Match!
Susan L. Hendrix
Wayne State University
140Publications
48H-index
19.4kCitations
Publications 140
Newest
#1Ann G. Schwartz (WSU: Wayne State University)H-Index: 54
#2Roberta M. Ray (Fred Hutchinson Cancer Research Center)H-Index: 36
Last.Charles Kooperberg (Fred Hutchinson Cancer Research Center)H-Index: 73
view all 17 authors...
Introduction: Results from the Women's Health Initiative clinical trials demonstrated no increase in the risk of lung cancer in postmenopausal women treated with hormone therapy (HT). We conducted a joint analysis of the Women's Health Initiative observational study data and clinical trials data to further explore the association between estrogen and estrogen-related reproductive factors and lung cancer risk. Methods: Reproductive history, oral contraceptive use, and postmenopausal HT were evalu...
#1S Wassertheil-Soller (Albert Einstein College of Medicine)H-Index: 60
#2Aileen P. McGinn (Albert Einstein College of Medicine)H-Index: 24
Last.Lisa W. Martin (GW: George Washington University)H-Index: 39
view all 11 authors...
Background Classification of risk of ischemic stroke is important for medical care and public health reasons. Whether addition of biomarkers adds to predictive power of the Framingham Stroke Risk or other traditional risk factors has not been studied in older women. Methods The Hormones and Biomarkers Predicting Stroke Study is a case-control study of blood biomarkers assayed in 972 ischemic stroke cases and 972 controls, nested in the Women's Health Initiative Observational Study of 93 676 post...
#1Elizabeth MaunsellH-Index: 7
#2Paul E. Goss (Harvard University)H-Index: 70
Last.Andrew L. CookeH-Index: 1
view all 27 authors...
Purpose Exemestane, a steroidal aromatase inhibitor, reduced invasive breast cancer incidence by 65% among 4,560 postmenopausal women randomly assigned to exemestane (25 mg per day) compared with placebo in the National Cancer Institute of Canada (NCIC) Clinical Trials Group MAP.3 (Mammary Prevention 3) trial, but effects on quality of life (QOL) were not fully described. Patients and Methods Menopause-specific and health-related QOL were assessed by using the four Menopause-Specific Quality of ...
#1R. Jeelani (WSU: Wayne State University)
#2Valerie I. Shavell (WSU: Wayne State University)H-Index: 12
Last.R. Asaad (WSU: Wayne State University)H-Index: 1
view all 6 authors...
#1R. Asaad (WSU: Wayne State University)H-Index: 1
#2R. Jeelani (WSU: Wayne State University)
Last.Michael P. Diamond (WSU: Wayne State University)H-Index: 67
view all 6 authors...
#1Nicole C. Wright (UA: University of Arizona)H-Index: 15
#2Jeffrey R. Lisse (UA: University of Arizona)H-Index: 27
Last.Joan McGowan (NIH: National Institutes of Health)H-Index: 14
view all 61 authors...
Objective. To examine the relationship between arthritis and fracture. Methods. Women were classified into 3 self-reported groups at baseline: no arthritis (n = 83,295), osteoarthritis (OA; n = 63,402), and rheumatoid arthritis (RA; n = 960). Incident fractures were self-reported throughout followup. Age-adjusted fracture rates by arthritis category were generated, and the Cox proportional hazards model was used to test the association between arthritis and fracture. Results. After an average of...
Objective— To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism. Methods and Results— The design was a nested case-control study in the Women's Health Initiative trials of postmenopausal hormone therapy. The study included all cases in the first 4 years: 359 cases of coronary heart disease, 248 of stroke, and 217 of venous thromboembolism. Six estrogen rec...
12345678910